Loading…
Vertical Toxoplasmosis in a Murine Model. Protection after Immunization with Antigens of Toxoplasma gondii Incorporated into Liposomes
Distinct Toxoplasma gondii antigens were entrapped within liposomes and evaluated for their ability to protect Balb/c mice against congenital transmission: soluble tachyzoite antigen (L/STAg), soluble tissue cyst antigen (L/SCAg), soluble tachyzoite plus tissue cyst (L/STCAg) or purified 32kDa antig...
Saved in:
Published in: | Memórias do Instituto Oswaldo Cruz 2001-01, Vol.96 (1), p.99-104 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Distinct Toxoplasma gondii antigens were entrapped within liposomes and
evaluated for their ability to protect Balb/c mice against congenital
transmission: soluble tachyzoite antigen (L/STAg), soluble tissue cyst
antigen (L/SCAg), soluble tachyzoite plus tissue cyst (L/STCAg) or
purified 32kDa antigen of tachyzoite (L/pTAg). Soluble tachyzoite
antigen alone in PBS (STAg) or emulsified in Freund's Complete Adjuvant
(FCA/STAg) was also evaluated. Dams were inoculated subcutaneously with
these antigens 6, 4 and 2 weeks prior to a challenge with four tissue
cysts of the P strain of T. gondii orally between 10 and 14 days of
pregnancy. Significant diminution differences were observed between the
frequency of infected pups born of the dams immunized with the antigens
incorporated into liposomes and that of pups born of the dams immunized
with antigen emulsified in FCA or non immunized group (p{0.05). There
was a significant decrease in the number of pups born dead in the
groups L/STAg, L/SCAg and L/pTAg when compared with pups from all other
groups (p {0.05). All dams immunized with or without adjuvant showed an
antibody response and a proliferation of T-cells. However, no
correlation was found between immune response and protection against
the challenge. |
---|---|
ISSN: | 1678-8060 0074-0276 0074-0276 1678-8060 |
DOI: | 10.1590/S0074-02762001000100011 |